Nitric oxide release: part II. Therapeutic applications

Area of Science:

• Biomaterials Science
• Nanotechnology
• Medical Therapeutics

Background:

• Nitric oxide (NO) has diverse biological roles, making NO-releasing materials potential therapeutics.
• Macromolecular scaffolds offer advantages over small molecules for NO storage and controlled delivery.
• Despite design advancements, clinical translation of NO-releasing macromolecules is limited.

Purpose of the Study:

• To review the therapeutic applications of macromolecular nitric oxide (NO) therapies.
• To evaluate the potential of NO-releasing scaffolds in various disease contexts.
• To bridge the gap between material design and clinical utility.

Main Methods:

• Literature review of in vitro and in vivo studies on macromolecular NO therapies.
• Analysis of different scaffold types (particles, dendrimers, polymers/films).
• Evaluation of NO-releasing materials for cardiovascular disease, cancer, bacterial infections, and wound healing.

Main Results:

• Macromolecular scaffolds demonstrate potential for enhanced NO delivery and therapeutic efficacy.
• Preliminary in vitro and in vivo data suggest promise across multiple disease areas.
• Challenges remain in realizing the full clinical utility of these advanced materials.

Conclusions:

• Macromolecular NO therapies represent a promising therapeutic strategy with broad applicability.
• Further research and development are needed to overcome barriers to clinical translation.
• NO-releasing scaffolds hold significant potential for treating cardiovascular disease, cancer, infections, and promoting wound healing.